The Stephen Review

National Blood Agreement & National Blood Authority Act 2003

National Blood Authority Board

Jurisdictional Blood Committee

Schedule 4 Process

Barcoding in the Blood Sector

The Stewardship Statement


Barcoding in the Blood Sector

The Jurisdictional Blood Committee (JBC) has endorsed the following National Policy on Barcoding for Blood and Blood Products:

This was endorsed by the JBC on 24 May 2007.

Background

At the request of a range of Stakeholders for a consistent policy in relation to barcoding requirements, the NBA undertook an extensive consultation process in 2006 that included public forum discussion and release of a discussion paper. Stakeholders indicated wide support for the adoption of a barcoding standard in the Blood Sector - the major point of difference between stakeholders was in relation to implementation timing, with most respondents recommending a 2 year implementation timeframe.

To support implementation of the standard, the NBA will undertake the following actions:

Update - Barcoding for Blood and blood Products


Following consideration of the outstanding technical, policy and capability requirements for the sector to move to the previously announced National Policy on Barcoding for Blood and Blood Products, JBC at its meeting of 28 May 2010, agreed to change the timing of full implementation of this standard, originally planed to be completed by 1 July 2011.


The NBA will now commence work with stakeholders including suppliers to fully understand current capability and obstacles to implementation and develop a project plan to complete the implementation of this policy. Details of the project plan and timelines will be announced following a consultation process.


For further details or questions, please contact John Burns at the NBA at barcoding@nba.gov.au

 

 

Feedback | Privacy | Copyright | Disclaimer | Contact Us

This page last modified on June 29, 2010
ABN 87 361 602 478 © Commonwealth of Australia 2010

BloodNet


Criteria for the Clinical Use of Intravenous Immunoglobulin (IVIg)


RFT 01/2012 - Review of the authorisation and clinical governance framework for intravenous immunoglobulin


AHMC Stewardship Statement


Patient Blood Management


Blood Supply to Australians Oversea


New supply arrangements for IVIg


Donate Blood